How much does a box of nirogacestat cost now?
Nirogacestat (nirogacestat) is a new type of small molecule drug mainly used to treat progressive desmoid tumors. This tumor is a benign tumor, but due to its aggressive growth characteristics, it may cause patients to have significant clinical symptoms and affect their quality of life. Nirogastat's mechanism of action is mainly by inhibiting γ-secretase, thereby interfering with the growth and survival pathways of tumor cells. This drug has shown good efficacy in clinical trials and can effectively control tumor growth and reduce patients' symptoms.

At present, nirogalastat has not yet been launched in the Chinese market, so the domestic usage and price information are not clear. However, according to relevant foreign information, this drug has been approved and put on the market in some countries. For example, in the United States, the typical specification of nirogacestat is 50mg*180 tablets, and the price per box is as high as approximately US$280,000, indicating its high economic burden. This is undoubtedly a huge challenge for many patients, especially when there is no medical insurance reimbursement.
Nirogastat is mainly indicated for adult patients who require systemic therapy, especially those with unresectable or recurrent solid tumors. The results of clinical trials show that patients treated with nilogastat have significant improvements in tumor control rate and progression-free survival. During the treatment process, patients may experience some side effects, such as nausea, fatigue, diarrhea, etc., but most side effects are relatively controllable, and doctors usually make adjustments based on the patient's specific situation.
In addition, there are currently no generic drugs of nilogacestat available overseas, which limits the availability of the drug and further increases the financial pressure on patients. Nonetheless, as the global research and development of anti-tumor drugs continues to deepen, more alternative treatment options may emerge in the future.
Reference materials:https://www.drugs.com/mtm/nirogacestat.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)